NK1 receptor antagonists

462 125 mg Pill - pink & white capsule-shape, 18mm

Generic Name: aprepitant

Pill with imprint 462 125 mg is Pink & White, Capsule-shape and has been identified as Emend 125 mg. It is supplied by Merck & Company Inc.

Emend is used in the treatment of Nausea/Vomiting, Chemotherapy Induced and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Emend (Aprepitant (oral/injection) [ a-prep-i-tant ])-462 125 mg-125 mg-Pink & White-Capsule-shape
Emend (Aprepitant (oral/injection) [ a-prep-i-tant ])-462 125 mg-125 mg-Pink & White-Capsule-shape

Emend
Generic Name: aprepitant (oral/injection) [ a-prep-i-tant ]
Imprint: 462 125 mg
Strength: 125 mg
Color: Pink & White
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: NK1 receptor antagonists
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00006-0462 (Discontinued)
Inactive Ingredients: Sucrose, Microcrystalline cellulose, Sodium lauryl sulfate, Titanium dioxide, Silicon dioxide, Ferric oxide red, Ferric oxide yellow,
Latest News
Related Drugs